Online Consultation For CAR-T Doctors in India

Chimeric Antigen Receptor T-cell (CAR-T) therapy is an advanced immunotherapy used to treat relapsed or refractory blood cancers, including certain types of leukemia, lymphoma, and multiple myeloma. Success depends on choosing a specialist trained in cellular immunotherapy, bone marrow transplantation, and hematological oncology.

• Board-certified Medical Oncologists or Hematologists
• Specialization in Hematologic Malignancies and Immunotherapy
• Fellowship training in Stem Cell or Cellular Therapy
• Affiliation with hospitals offering GMP labs and CAR-T trials

CAR-T therapy requires ultra-specialised infrastructure with GMP cell processing labs, cryopreservation units, immunotherapy-trained teams, and infection-controlled environments.

• NABH or JCI accreditation
• Cellular Therapy & Transplantation Units
• Apheresis and cryopreservation facilities
• Access to clinical trials for CAR-T innovations
• Comprehensive supportive care: ICU, infection control, cytokine-release management

Yes. MediGence and major hospitals offer virtual consultations with CAR-T specialists.

• Upload prior treatment summaries (chemotherapy, stem cell transplant, etc.)
• Biopsy and immunophenotyping reports
• Flow cytometry and cytogenetic test results
• Imaging scans (PET, CT, bone marrow biopsy reports)
• Previous MRD (minimal residual disease) status

• Eligibility will be assessed based on disease stage and response to prior treatments
• Biomarkers will be evaluated
• The specialist will explain the CAR-T process including T-cell collection, Lab modification, Infusion and post-infusion monitoring
• The timeline and cost estimate will be shared

Stage & Duration

Pre-evaluation & screening: 5–7 days

Apheresis (T-cell collection): 1 day

Cell manufacturing & shipping (local or overseas lab): 2–3 weeks (off-site)

Infusion & hospital stay: 10–14 days

Cytokine-release monitoring & recovery: 2–3 weeks

Total Recommended Stay: 4–6 weeks

Yes. India is a rapidly growing hub for affordable and cutting-edge cancer immunotherapy.

• International patient help desks
• Visa facilitation and pre-approval medical letters
• CAR-T cell procurement coordination (India or overseas)
• Hotel accommodation and airport transfer support
• Language interpretation and post-discharge care planning

Credential & Details

Medical Degree: MBBS + DM (Medical Oncology) or MD + DM (Hematology)

Fellowship: Immunotherapy, Cellular Therapy, or Bone Marrow Transplant

Certifications: ISCT, EBMT, or ASH-accredited training

Experience: ≥5 years in CAR-T, HSCT, or hematologic oncology

Institutional Support: CAR-T approval at a JCI/NABH-accredited institute

You’ll receive:

• A review of your clinical history, including relapse or refractory disease
• Biomarker matching for CAR-T cell suitability (e.g., CD19, BCMA)
• Explanation of risks (e.g., cytokine release syndrome, neurotoxicity) & benefits (MRD negativity, long-term remission)
• Estimated cost and timeline
• Follow-up protocol: blood monitoring, MRD tests, infection precautions

Yes, MediGence provides access to expert second opinions for a wide range of medical conditions, including cancer, cardiology, neurosurgery, and more. Patients can securely upload medical reports—such as scans, lab results, and treatment history and receive a personalised assessment from top specialists. The service offers guidance on diagnosis confirmation, treatment options, and cost estimates, and is available to both local and international patients through virtual consultations or written reviews.